YOLFTbeta
Imunon Inc

Imunon Inc

IMNN · NASDAQ · Healthcare / Biotechnology

0.63USD-0.01 (-1.07%)

Price History

Full chart

Market Stats

Previous Close0.6368
Open0.58
Day Range0.55 – 0.63
52-Week Range1.30 – 5.55
Volume175.30K
Market Cap7.74M
P/E (TTM)0.00
Forward P/E16.78
EPS-2.92
Dividend Yield0.00%
Beta1.98
50-Day Avg1.56
200-Day Avg2.57

About

Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma. It is also developing IMNN-101, a COVID-19 booster vaccine that has completed a Phase 1 clinical trial. In addition, the company develops non-viral DNA technology across modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was incorporated in 1982 and is headquartered in Lawrenceville, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Stacy R. Lindborg Ph.D.
  • Employees20
  • Headquarters997 Lenox Drive, Lawrenceville, NJ, United States, 08648, USA
  • Websitehttps://imunon.com

Leadership

  • Mr. Michael H. TardugnoExecutive Chairman · b. 1951
  • Dr. Stacy R. Lindborg Ph.D.President, CEO & Director · b. 1971
  • Dr. Douglas V. Faller M.D., Ph.D.Chief Medical Officer · b. 1953
  • Mr. Joshua Blacher CPA, M.B.A.Interim CFO, Principal Financial Officer & Principal Accounting Officer · b. 1973

Financials

Income Statement

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue74.01K121.26K174.18K100.00K3.42K---2.51M12.32M11.25M-2.50M--2.00M-500.00K500.00K500.00K500.00K500.00K500.00K500.00K500.00K500.00K500.00K125.00K00
Growth (%)-+63.85%+43.65%-42.59%-96.58%----+391.58%-8.68%-------0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-75.00%-100.00%-
Cost of Revenue64.41K46.73K136.50K--39.23K---2.10M8.11M6.67M----------13.08M11.07M13.07M11.34M702.92K731.63K720.00K718.12K-
Gross Profit9.60K74.52K37.68K100.00K42.65K---405.34K4.21M4.58M-2.50M--2.00M-500.00K500.00K500.00K500.00K500.00K500.00K500.00K500.00K500.00K500.00K-720.00K-718.12K-
Gross Margin12.97%61.46%21.63%100.00%1247.13%---16.17%34.15%40.72%-100.00%--100.00%-100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-576.00%--
Operating Expense1.43M2.47M4.05M2.40M4.94M---15.00M13.49M13.07M-14.05M--25.02M-15.91M25.22M21.35M21.15M18.97M21.57M21.07M18.99M21.51M25.42M20.31M18.41M-
Operating Income-1.42M-2.39M-4.01M-2.30M-4.90M-7.29M-9.84M-13.30M-14.60M-9.28M-8.49M-13.59M-11.55M-17.01M-19.64M-23.02M-22.14M-15.41M-24.72M-20.85M-20.65M-18.47M-21.07M-20.57M-18.49M-21.01M-24.92M-21.03M-19.13M-14.65M
Operating Margin-1922.52%-1974.89%-2303.92%-2300.00%-143171.08%----582.51%-75.32%-75.43%--461.98%---1150.94%--3082.30%-4943.04%-4169.36%-4129.96%-3693.69%-4213.01%-4113.09%-3697.28%-4201.44%-4984.31%-16824.34%--
EBITDA-1.40M-2.37M-3.99M-2.40M-4.86M-7.26M-9.79M-13.20M-14.87M-9.60M-9.84M-13.14M-11.58M-15.80M-18.61M-22.55M-21.86M-7.00M-23.80M-20.68M-20.31M-19.76M-21.23M-16.55M-21.30M-20.88M-31.71M-19.88M-17.90M-13.80M
EBITDA Margin-1897.46%-1954.96%-2289.97%-2400.00%-142016.75%----593.51%-77.93%-87.46%--463.01%---1127.57%--1399.38%-4759.70%-4135.79%-4061.58%-3951.48%-4246.72%-3310.59%-4259.10%-4175.98%-6341.00%-15902.62%--
Net Income-1.93M-3.05M-4.20M-2.40M-4.55M-6.92M-9.75M-13.27M-13.99M-8.69M-7.58M35.35M-11.79M-15.19M-18.82M-23.22M-26.57M-8.25M-25.49M-22.46M-22.05M-20.40M-11.88M-16.85M-21.48M-20.77M-35.90M-19.51M-18.62M-14.49M
Net Income Margin-2612.59%-2516.88%-2411.55%-2400.00%-132959.50%----558.01%-70.50%-67.41%--471.45%---1161.13%--1650.27%-5098.85%-4492.22%-4410.75%-4080.44%-2376.67%-3370.31%-4296.71%-4153.85%-7179.65%-15611.98%--
R&D94.01K185.97K1.53M1.00M2.24M4.08M5.00M8.18M11.53M10.08M9.35M8.23M12.01M13.68M14.71M19.86M15.77M9.36M14.97M14.66M14.62M13.08M11.87M13.07M11.34M10.62M11.73M11.29M11.64M7.78M
R&D as % of Total Revenue127.03%153.37%881.19%1000.00%65447.13%---460.19%81.83%83.06%-480.25%--993.19%-1872.85%2993.88%2931.99%2924.61%2615.74%2373.10%2613.06%2268.96%2123.86%2346.73%9030.15%--
Interest Expense85.51K-199.35K2.30M4.55M6.92M9.75M13.27M-179.59K1.10M49.42M141.61K94.92K31.52K501.86K307.00K915.24K1.33M1.36M722.99K91.76K712.02K1.39M1.29M569.88K5.03M197.08K0-
Interest Expense % of Total Revenue115.54%-114.45%2300.00%132959.50%----1.46%9.81%-5.66%--25.09%-183.05%265.29%271.44%144.60%18.35%142.41%278.68%258.47%113.98%1005.72%157.66%--

Balance Sheet

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets9.32M823.21K330.74K1.60M9.12M2.96M2.29M14.44M17.05M15.91M18.93M39.04M23.69M14.81M2.53M32.65M25.36M45.67M66.69M49.03M30.85M47.51M46.86M38.28M37.53M74.05M43.98M21.92M9.72M12.29M
Total Liabilities2.57M3.28M2.18M600.00K391.39K287.64K774.96K986.84K5.08M12.48M22.13M8.39M3.96M4.77M7.10M6.46M13.40M14.15M33.87M28.64M24.12M20.81M25.99M23.72M18.92M18.25M14.65M8.53M5.47M5.23M
Total Equity6.76M-2.46M-1.85M1.00M8.73M2.67M1.52M13.45M11.97M3.43M-3.20M30.65M19.73M10.04M-4.58M26.19M11.96M31.52M32.83M20.39M6.73M26.70M20.86M14.56M18.61M55.80M29.33M13.39M4.24M7.06M
Cash246.93K267.35K54.92K1.40M8.82M2.51M928.82K12.27M586.38K2.31M1.03M2.94M3.46M6.92M1.14M20.15M14.99M5.72M12.69M9.27M2.62M11.44M13.35M6.88M17.16M19.59M11.49M5.84M5.87M8.78M
Total Debt1.54M1.59M285.62K100.00K114.78K----6.18M16.28M911.60K234.74K288.20K179.87K181.89K5.07M5.01M9.71M6.42M2.56M-9.42M11.34M6.19M6.63M6.27M1.62M1.14M1.01M
Net Debt1.30M1.32M230.70K-1.30M-8.71M-2.51M-928.82K-12.27M-586.38K3.86M15.25M-2.03M-3.22M-6.64M-959.05K-19.96M-9.92M-707.61K-2.98M-2.84M-63.61K-11.44M-3.94M4.46M-10.97M-12.95M-5.23M-4.21M-4.73M-7.77M

Cash Flow

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.46M-1.15M-2.11M-2.30M-3.87M-6.22M-9.11M-9.09M-13.94M-8.06M-7.23M-9.58M2.28M-930.33K-13.37M-22.74M-22.14M-9.53M-21.35M-20.83M-18.38M-16.64M-7.04M-20.26M-15.62M-16.22M-23.10M-19.02M-18.85M-13.90M
Investing Cash Flow128.74K-3.81K-31.93K--122.11K-124.32K-98.62K-111.85K-5.58M3.79M-3.05M13.21M-1.09M-1.70M5.21M-11.09M1.47M-29.14M9.54M13.33M9.06M-10.99M-1.63M5.94M7.92M-30.12M8.28M11.01M9.83M-280.57K
Financing Cash Flow1.57M1.18M1.93M3.60M11.45M37.72K7.63M19.68M12.84M6.00M9.00M-1.72M-676.87K6.10M2.38M52.84M15.52M29.39M18.78M4.08M2.68M36.45M10.58M7.84M17.98M54.77M6.72M-3.64M9.06M17.09M
Capital Expenditure10.26K3.81K21.93K0122.11K117.57K89.33K111.85K484.06K108.52K262.82K1.69M24.23K136.22K6.75K573.41K613.39K57.49K672.26K109.34K62.50K38.63K138.40K349.16K19.09K311.61K267.80K451.76K29.54K280.57K
Free Cash Flow-1.47M-1.16M-2.13M-2.30M-3.99M-6.34M-9.20M-9.20M-14.43M-8.17M-7.50M-11.27M2.26M-1.07M-13.37M-23.32M-22.76M-9.58M-22.03M-20.94M-18.44M-16.68M-7.18M-20.61M-15.64M-16.54M-23.36M-19.47M-18.88M-14.18M
Dividends Paid----------------------------010.28K
FCF to OCF100.70%100.33%101.04%100.00%103.16%101.89%100.98%101.23%103.47%101.35%103.63%117.65%98.94%114.64%100.05%102.52%102.77%100.60%103.15%100.52%100.34%100.23%101.97%101.72%100.12%101.92%101.16%102.37%100.16%102.02%
Dividend Paid to FCF----------------------------0.00%-0.07%

Earnings

Report DateDec 31, 1998Mar 31, 1999Jun 30, 1999Dec 31, 1999Jun 30, 2000Dec 28, 2000Feb 8, 2001Mar 31, 2001Jun 30, 2001Sep 30, 2001Feb 27, 2002May 14, 2002Aug 13, 2002Dec 30, 2002Feb 15, 2003May 15, 2003Aug 14, 2003Dec 29, 2003Aug 6, 2004Nov 12, 2004Mar 3, 2005May 11, 2005Aug 8, 2005Nov 9, 2005Feb 28, 2006May 8, 2006Aug 10, 2006Nov 8, 2006Feb 22, 2007May 11, 2007Aug 10, 2007Nov 8, 2007Feb 21, 2008May 9, 2008Aug 18, 2008Nov 13, 2008Mar 3, 2009May 12, 2009Aug 5, 2009Nov 10, 2009Feb 17, 2010May 4, 2010Aug 3, 2010Nov 15, 2010Mar 25, 2011May 13, 2011Aug 9, 2011Nov 10, 2011Mar 15, 2012May 15, 2012Aug 14, 2012Nov 12, 2012Mar 18, 2013May 9, 2013Aug 8, 2013Nov 12, 2013Mar 13, 2014May 8, 2014Aug 7, 2014Nov 11, 2014Mar 12, 2015May 11, 2015Aug 10, 2015Nov 5, 2015Mar 30, 2016May 16, 2016Aug 15, 2016Nov 10, 2016Mar 16, 2017May 12, 2017Aug 14, 2017Nov 14, 2017Mar 27, 2018May 11, 2018Aug 14, 2018Nov 14, 2018Mar 29, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 25, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Mar 19, 2021May 14, 2021Aug 12, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 30, 2023May 11, 2023Aug 10, 2023Nov 14, 2023Mar 28, 2024May 13, 2024Aug 14, 2024Nov 7, 2024Mar 26, 2025May 12, 2025Aug 5, 2025Nov 13, 2025Dec 31, 2025May 12, 2026Aug 11, 2026Nov 12, 2026
EPS Estimate------3697.89-18.90-----7395.78-5546.83-5546.83-283.50--------------------------340.20-3944.40-4684.00-4560.74-4437.48---3143.21-226.80-2835.05-2342.00-2126.29-160.65-1972.22-862.83-739.57-753.27-50.40-958.70-931.31-999.79-69.30-849.14-705.33-49.87-582.07-566.09-556.96-38.85-301.31-74.35-109.57-4.57-58.70-52.83-43.04-2.05-48.91-64.57-52.83-39.13-2.55-29.35-25.43-25.43-0.06-1.20-16.63-0.90-13.30-11.80-10.30-0.85-8.09-7.70-7.30-0.41-7.39-6.65-5.35-0.36-4.66-4.34-1.82-1.82-1.28-0.94-0.61
EPS Actual-2495.84-2582.91-1685.06-2866.64-2821.86-5546.83-18.90-4045.40-3906.38-5546.74-3899.04-7395.78-5546.83-5546.83-296.25-8229.79-4676.69-5589.91-7319.44-1697.31-3810.37-2533.45-2762.40-2245.18-2440.68-2048.40-4275.27-1137.82-1249.04-2704.1246867.05-4138.68-2716.21-4960.16-2952.21-5271.04-1133.80-4374.72-5550.47-5746.86-179.55-6163.15-2711.79-5177.04-6779.46-3448.98-5229.77-3315.77-170.10-1435.52-2218.73-2218.73-198.45-1479.16123.26-714.92-512.22-69.30-875.19-965.77-905.56-73.50-739.57-520.44-50.40-657.40-520.44-630.00-39.90-328.70-154.57-136.96-4.68-48.91-90.00-50.87-4.20-23.48-56.74-48.91-19.57-3.00-35.22-46.96-9.78-1.35-0.90-11.74-3.62-23.74-11.35-11.35-1.61-8.87-7.46-4.83-0.52-6.78-6.65-4.43-0.25-3.65-1.87-1.16-1.30-0.84-0.54-
Surprise------50.00%0.00%----0.00%0.00%0.00%-4.50%-------------------------47.22%-56.25%42.11%-13.51%-52.78%---5.49%25.00%49.37%5.26%-4.35%-23.53%25.00%114.29%3.33%32.00%-37.50%8.71%-3.70%9.43%-6.06%12.90%26.21%-1.06%-12.94%8.06%-13.11%-2.70%-9.09%-107.90%-25.00%-2.41%16.68%-70.36%-18.19%-104.88%51.99%12.13%7.42%49.99%-17.65%-20.00%-84.66%61.54%-2150.00%25.00%29.40%-302.22%-78.50%3.81%-10.19%-89.41%-9.64%3.12%33.84%-26.83%8.25%0.00%17.20%30.56%21.67%56.91%36.26%28.57%34.38%42.55%-
Timing-----------------------------------------Pre-marketPre-marketAfter-hoursPre-market--Pre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap7.74M
Enterprise Value9.23M
Trailing P/E0.00
Forward P/E16.78
PEG Ratio5.03
Price / Sales17.94
Price / Book1.97
EPS-2.92
Book Value0.415
Revenue (TTM)125.00K
Gross Profit (TTM)-409.92K
EBITDA-14.55M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-429.72%
Return on Assets-77.99%
Shares Outstanding5.61M
Shares Float5.28M
Beta1.98
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 4 analystsTarget 17.00
  • Strong Buy
    2
  • Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
5.68%
Insiders
5.73%
Retail / Other
88.59%

Top Institutional Holders

  • Armistice Capital, LLC
    348.33K6.21%
  • Vanguard Capital Management, LLC
    48.06K0.86%
  • Riverview Capital Advisers LLC
    34.36K0.61%
  • Geode Capital Management, LLC
    33.21K0.59%
  • Vanguard Fiduciary Trust Co
    13.27K0.24%
  • HRT FINANCIAL LLC
    12.05K0.21%
  • BlackRock Inc
    4.46K0.08%
  • Wells Fargo & Co
    3.34K0.06%
  • Morgan Stanley - Brokerage Accounts
    3.04K0.05%
  • Tower Research Capital LLC
    1.87K0.03%
  • SBI Securities Co Ltd
    1.03K0.02%
  • UBS Group AG
    5750.01%
  • Group One Trading, LLC
    60.00%
  • Federation des caisses Desjardins du Quebec
    50.00%
  • DRW Securities, LLC
    00.00%
  • Advisor Group Holdings, Inc.
    20.00%
  • Steigerwald, Gordon & Koch Inc.
    10.00%

Top Fund Holders

  • Fidelity Extended Market Index
    18.99K0.34%
  • Fidelity Series Total Market Index
    4.74K0.08%
  • Fidelity Total Market Index
    1.78K0.03%

Stock Splits

  • Aug 7, 2025115:100
  • Mar 1, 20221:15
  • May 30, 20171:14
  • Oct 29, 2013222:1000
  • Feb 28, 20061:15